Stay updated with breaking news from Nasdaq Slno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) shares shot up 3.6% during mid-day trading on Tuesday . The stock traded as high as $49.00 and last traded at $49.00. 65,622 shares traded hands during trading, a decline of 74% from the average session volume of 249,337 shares. The stock had previously closed at $47.32. […]
Piper Sandler began coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a research note released on Monday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $93.00 target price on the stock. A number of other equities analysts also recently weighed in on SLNO. Guggenheim reissued a buy rating […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report)’s share price traded down 4.3% on Tuesday . The stock traded as low as $47.38 and last traded at $47.39. 171,504 shares were traded during trading, a decline of 31% from the average session volume of 248,250 shares. The stock had previously closed at $49.50. Wall Street […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 2,527 shares of Soleno Therapeutics stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $48.30, for a total value of $122,054.10. Following the completion of the transaction, the chief executive officer now owns […]
Stifel Nicolaus began coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a report released on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $63.00 price objective on the stock. SLNO has been the topic of a number of other reports. Guggenheim reissued a buy rating and issued a […]